Investigating Neural Biomarkers for Gait in Parkinson's Patients

Recruiting Observational Study
Parkinson Disease Gait Disorders, Neurologic
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
Swiss Federal Institute of Technology · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This observational study's main goal is to learn more about the neural mechanisms during movement in Parkinson's disease. Furthermore, it aims to inspire personalised treatment options. Participants will undergo a protocol that involves walking and gait-related motor tasks, such as seated stepping. During the protocol, brain activity will be recorded.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: All participants * must have given informed consent as documented by signature * agree to comply with the study procedures Healthy control group * no neurological, orthopedic, or rheumatologic disease history * no identified sensory impairment. * no epilepsy and self-diagnose…
Contacts

Lena Salzmann, MSc

+41788248679

lena.salzmann@hest.ethz.ch

CONTACT

Olivier Lambercy, PhD

oliver.lambercy@hest.ethz.ch

CONTACT